Form D
View Original Filing
Notice of Exempt Offering of Securities
Item 1. Issuer's Identity
Name of Issuer:
THERAPEUTICSMD, INC.
Jurisdiction of Incorporation/Organization
NE
Year of Incorporation/Organization
2010
Previous Name(s)
- AMHN, INC.
- CROFF ENTERPRISES INC
- CROFF OIL CO
Item 2 Issuer Principal Place of Business and Contact Information
951 BROKEN SOUND PARKWAY NW
SUITE 320
BOCA RATON, FL 33487
Phone Number:
subscription required
Item 3. Related Persons
Name
ROBERT G. FINIZIO
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
JOHN C.K. MILLIGAN IV
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
DANIEL A. CARTWRIGHT
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
MITCHELL L. KRASSAN
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
BRIAN BERNICK, M.D.
Address
subscription required
Relationship(s)
- EXECUTIVE OFFICER
- DIRECTOR
Clarification of Response
Item 3. Related Persons
Name
TOMMY G. THOMPSON
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
SAMUEL A. GRECO
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
COOPER C. COLLINS
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
ROBERT V. LAPENTA, JR.
Address
subscription required
Relationship(s)
Clarification of Response
Item 3. Related Persons
Name
NICHOLAS SEGAL
Address
subscription required
Relationship(s)
Clarification of Response
Item 4. Industry Group
PHARMACEUTICALS
Item 5. Issuer Size
Revenue Range (for issuer not specifying "hedge" or "other investment" fund in Item 4 above)
DECLINE TO DISCLOSE
Item 6. Federal Exemptions and Exclusions Claimed
Item 7. Type of Filing
New Notice
Date of First Sale in this Offering:
09/26/2012
Item 8. Duration of Offering
Does the issuer intend this offering to last more than one year?
No
Item 9. Type(s) of Securities Offered
Item 10. Business Combination Transaction
Is this offering being made in connection with a business combination
transaction, such as a merger, acquisition or exchange offer?
No
Clarification of Response
Item 11. Minimum Investment
Minimum Investment accepted from any outside investor
0
Item 12. Sales Compensation
Recipient
JEFFERIES COMPANY, INC.
Recipient CRD Number
2347
(Associated) Broker or Dealer)
NONE
(Associated) Broker or Dealer CRD Number
NONE
Address
520 MADISON AVENUE
16TH FLOOR
NEW YORK, NY 10022
States of Solicitation
Item 13. Offering and Sales Amounts
Total Offering Amount
8500001
Total Amount Sold
8500001
Total Remaining to be Sold
0
Clarification of Response
Item 14. Investors
Securities in the offering have been or may be sold to persons
who do not qualify as accredited investors,
Number of non-accredited investors who already have invested in the offering:
Total number of investors who already have invested in the offering:
8
Item 15. Sales Commissions and Finders' Fees Expenses
Sales Commissions:
552500.0
Finders' Fees
0.0
Clarification of Response
THE AMOUNT REPRESENTS FEES EARNED BY JEFFERIES COMPANY, INC. FOR ITS SERVICES AS EXCLUSIVE PLACEMENT AGENT.
Item 16. Use of Proceeds
Provide the amount of the gross proceeds of the offering
that has been or is proposed to be used for payments to any of the persons required
to be named as executive officers,directors or promoters in response to Item 3 above.
0.0
Clarification of Response
Signature and Submission
Issuer Name
THERAPEUTICSMD, INC.
Issuer Signature
/S/ DANIEL A. CARTWRIGHT
Signer Name
DANIEL A. CARTWRIGHT
Signer Title
CHIEF FINANCIAL OFFICER
Signature Date
10/10/2012